| 000 | 01507 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250513141321.0 | ||
| 264 | 0 | _c19980527 | |
| 008 | 199805s 0 0 eng d | ||
| 022 | _a0065-2598 | ||
| 024 | 7 |
_a10.1007/978-1-4899-1819-2_7 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHarding, E A | |
| 245 | 0 | 0 |
_aNovel actions of the potassium channel modulator SDZ PCO 400 on ATP-regulated potassium channels in insulin secreting cells. SDZ PCO 400 and beta-cells. _h[electronic resource] |
| 260 |
_bAdvances in experimental medicine and biology _c1997 |
||
| 300 |
_a51-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAdenosine Triphosphate _xpharmacology |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBenzopyrans _xpharmacology |
| 650 | 0 | 4 | _aCell Line |
| 650 | 0 | 4 | _aCells, Cultured |
| 650 | 0 | 4 |
_aCyclopentanes _xpharmacology |
| 650 | 0 | 4 |
_aGuanidines _xpharmacology |
| 650 | 0 | 4 | _aIon Channel Gating |
| 650 | 0 | 4 |
_aIslets of Langerhans _xdrug effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMembrane Potentials _xdrug effects |
| 650 | 0 | 4 | _aPatch-Clamp Techniques |
| 650 | 0 | 4 |
_aPhentolamine _xpharmacology |
| 650 | 0 | 4 | _aPinacidil |
| 650 | 0 | 4 |
_aPotassium Channels _xdrug effects |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Wistar |
| 700 | 1 | _aDunne, M J | |
| 773 | 0 |
_tAdvances in experimental medicine and biology _gvol. 426 _gp. 51-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/978-1-4899-1819-2_7 _zAvailable from publisher's website |
| 999 |
_c9511713 _d9511713 |
||